Shoushtari, A. N., Friedman, C. F., Navid-Azarbaijani, P., Postow, M. A., Callahan, M. K., Momtaz, P., . . . Chapman, P. B. (2018). Measuring Toxic Effects and Time to Treatment Failure for Nivolumab Plus Ipilimumab in Melanoma. JAMA oncology, 4(1), 98. https://doi.org/10.1001/jamaoncol.2017.2391
Citace podle Chicago (17th ed.)Shoushtari, Alexander N., Claire F. Friedman, Pedram Navid-Azarbaijani, Michael A. Postow, Margaret K. Callahan, Parisa Momtaz, Katherine S. Panageas, Jedd D. Wolchok, a Paul B. Chapman. "Measuring Toxic Effects and Time to Treatment Failure for Nivolumab Plus Ipilimumab in Melanoma." JAMA Oncology 4, no. 1 (2018): 98. https://doi.org/10.1001/jamaoncol.2017.2391.
Citace podle MLA (9th ed.)Shoushtari, Alexander N., et al. "Measuring Toxic Effects and Time to Treatment Failure for Nivolumab Plus Ipilimumab in Melanoma." JAMA Oncology, vol. 4, no. 1, 2018, p. 98, https://doi.org/10.1001/jamaoncol.2017.2391.